Albert Einstein University of Medicine receives SU2C grant for cancers research Matthew Levy.

This represents a thrilling new avenue of study at Einstein directed to the development of therapies that particularly target malignancy cells. This award to Dr. Levy is an extremely appropriate honor for his novel analysis applying chemical biology approaches to cancer problems, stated Vern Schramm, Ph.D., the Ruth Merns Chair in Biochemistry, who recruited Levy to become listed on Einstein’s faculty in 2007. His study typifies the integration of brand-new technology across disciplines to possess effect on fundamental chemistry concepts in addition to in human disease. In receiving the SU2C grant, Dr.Commenting upon this enhancement to prescription medication monitoring in the state, Larry Driver, MD, President-elect of the Texas Pain Society observed, ‘PAINWeekEnd Houston provides frontline clinicians a fantastic opportunity to upgrade their discomfort management skills, and to find out how to use the PAT program for the benefit and safety of their patients.on Saturday ‘ PAINWeekEnd Houston will be kept, May 10, at the Marriott Houston Westchase, on 2900 Briarpark Drive.S.S.